You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Details for Patent: 10,436,802


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,436,802 protect, and when does it expire?

Patent 10,436,802 protects SPINRAZA and is included in one NDA.

This patent has five patent family members in four countries.

Summary for Patent: 10,436,802
Title:Methods for treating spinal muscular atrophy
Abstract: Disclosed herein are compounds, compositions and methods for modulating splicing of SMN2 mRNA in a subject. Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders, including spinal muscular atrophy. Also provided are kits for detecting the amount of SMN protein in a sample of cerebrospinal fluid.
Inventor(s): Rigo; Frank (Carlsbad, CA), Bishop; Katherine M. (San Diego, CA)
Assignee: Biogen MA Inc. (Cambridge, MA)
Application Number:15/509,642
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 10,436,802

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Biogen Idec SPINRAZA nusinersen sodium SOLUTION;INTRATHECAL 209531-001 Dec 23, 2016 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial TREATMENT OF TYPE III SPINAL MUSCULAR ATROPHY ⤷  Try a Trial
Biogen Idec SPINRAZA nusinersen sodium SOLUTION;INTRATHECAL 209531-001 Dec 23, 2016 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial TREATMENT OF SPINAL MUSCULAR ATROPHY ⤷  Try a Trial
Biogen Idec SPINRAZA nusinersen sodium SOLUTION;INTRATHECAL 209531-001 Dec 23, 2016 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial TREATMENT OF INFANTILE-ONSET SPINAL MUSCULAR ATROPHY ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,436,802

PCT Information
PCT FiledSeptember 11, 2015PCT Application Number:PCT/US2015/049598
PCT Publication Date:March 17, 2016PCT Publication Number: WO2016/040748

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.